Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death

被引:0
|
作者
Perrine Kafara
Philippe Icard
Marilyne Guillamin
Laurent Schwartz
Hubert Lincet
机构
[1] INSERM,
[2] U 1199,undefined
[3] Unité BioTICLA,undefined
[4] Normandie Université France,undefined
[5] Centre de Lutte Contre le Cancer François Baclesse,undefined
[6] UMR 7161,undefined
[7] Laboratoire d’Informatique LIX,undefined
[8] Ecole Polytechnique,undefined
[9] UMR INSERM U1052,undefined
[10] CNRS 5286,undefined
[11] Centre de Recherche en Cancérologie de Lyon,undefined
[12] ISPB,undefined
[13] Faculté de Pharmacie de Lyon,undefined
[14] Université de Lyon 1,undefined
关键词
Lipoic acid; Mcl-1; Bcl-x; Bim; ovarian cancer; ROS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Tetrazole and acylsulfonamide bioisosteric replacements of the carboxylic acid in a dual MCL-1/BCL-xL inhibitor are tolerated
    Chen, Lijia
    Lowe, Brandon
    Fletcher, Steven
    RSC ADVANCES, 2023, 13 (49) : 34322 - 34334
  • [22] Differential impact of the endogenous Bak inhibitors Mcl-1 and Bcl-xL on death receptor-induced apoptosis
    Gillissen, B.
    Wendt, J.
    Hemmati, P. G.
    Overkamp, T.
    Richter, A.
    Mueer, A.
    Milojkovic, A.
    Preissner, R.
    Belka, C.
    Doerken, B.
    Daniel, P. T.
    ONKOLOGIE, 2010, 33 : 293 - 294
  • [23] Distribution of Bim Determines MCL-1 Dependence or Co-Dependence on BCL-xL/BCL-2 In Multiple Myeloma.
    Boise, Lawrence H.
    Morales, Alejo A.
    Kurtoglu, Metin
    Matulis, Shannon M.
    Markovitz, Rebecca
    Lee, Kelvin P.
    Lonial, Sagar
    BLOOD, 2010, 116 (21) : 1652 - 1652
  • [24] Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells
    Puthier, D
    Derenne, S
    Barillé, S
    Moreau, P
    Harousseau, JL
    Bataille, R
    Amiot, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) : 392 - 395
  • [25] MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
    Hartman, Mariusz L.
    Talar, Beata
    Gajos-Michniewicz, Anna
    Czyz, Malgorzata
    PLOS ONE, 2015, 10 (06):
  • [26] MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells
    Boucher, MJ
    Morisset, J
    Vachon, PH
    Reed, JC
    Lainé, J
    Rivard, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 79 (03) : 355 - 369
  • [27] The sensitivity of ovarian cancer cells to the HDAC inhibitor belinostat is improved by inhibiting Bcl-xL or Mcl-1 anti-apoptotic proteins
    Duboc, Charlene
    Abeilard, Edwige
    Voisin-Chiret, Anne Sophie
    Gauduchon, Pascal
    Poulain, Laurent
    Villedieu, Marie
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Synergistic Activity of Combined Targeting of BCL-2 with MCL-1 or BCL-Xl in B-Cell Precursor All
    Seyfried, F.
    Stirnweiss, F.
    Niedermayer, A.
    Enzenmuller, S.
    Horl, R.
    Kohrer, S.
    Debatin, K. -M.
    Meyer, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S161 - S161
  • [29] Contribution of A1 to macrophage survival in cooperation with MCL-1 and BCL-XL in a murine cell model of myeloid differentiation
    Vier, Juliane
    Haecker, Georg
    Kirschnek, Susanne
    CELL DEATH & DISEASE, 2024, 15 (09):
  • [30] Mcl-1, Bcl-xL and cell cycle inhibition by GCS-100:: A novel therapy for myeloma.
    Streetly, Matthew
    Su, Bo
    Carver, Bradley
    Schey, Stephen A.
    Cotter, Finbarr E.
    BLOOD, 2006, 108 (11) : 990A - 990A